199 related articles for article (PubMed ID: 9738596)
1. Late pulmonary toxicity of bleomycin.
Willenbacher W; Mumm A; Bartsch HH
J Clin Oncol; 1998 Sep; 16(9):3205. PubMed ID: 9738596
[No Abstract] [Full Text] [Related]
2. [Bleomycin-induced pneumonia].
Berger K; Göpfert A; Berkel H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Nov; 31(9):577-81. PubMed ID: 9063925
[TBL] [Abstract][Full Text] [Related]
3. Flagellate erythema secondary to bleomycin.
Khaliq W; Antonarakis ES
QJM; 2012 Sep; 105(9):901. PubMed ID: 21865305
[No Abstract] [Full Text] [Related]
4. Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy.
Andrade RS; Kesler KA; Wilson JL; Brooks JA; Reichwage BD; Rieger KM; Einhorn LH; Brown JW
Ann Thorac Surg; 2004 Oct; 78(4):1224-8; discussion 1228-9. PubMed ID: 15464475
[TBL] [Abstract][Full Text] [Related]
5. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of advanced testicular cancer and toxicity of chemotherapy].
Kawakita M; Matsuda T; Terachi T; Yoshida O
Hinyokika Kiyo; 1999 Nov; 45(11):783-6. PubMed ID: 10637744
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for good-risk germ-cell tumors.
Ryan CJ; Bajorin DF
Semin Urol Oncol; 2002 Nov; 20(4):244-50. PubMed ID: 12489057
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin and scuba diving: to dive or not to dive?
Huls G; ten Bokkel Huinink D
Neth J Med; 2003 Feb; 61(2):50-3. PubMed ID: 12735422
[TBL] [Abstract][Full Text] [Related]
11. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
Sweeney C
Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
[TBL] [Abstract][Full Text] [Related]
12. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease.
Real E; Roca MJ; Viñuales A; Pastor E; Grau E
Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918
[No Abstract] [Full Text] [Related]
13. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin lung: the effect of different chemotherapeutic regimens.
Chisholm RA; Dixon AK; Williams MV; Oliver RT
Cancer Chemother Pharmacol; 1992; 30(2):158-60. PubMed ID: 1376217
[TBL] [Abstract][Full Text] [Related]
15. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
Ahmed BM; Al-Zakwani IS
J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment of Pituitary Germinoma with Etoposide, Cisplatin, Vincristine, Methotrexate and Bleomycin Chemotherapy Without Radiotherapy.
Scherz A; Feller K; Berezowska S; Genitsch V; Zweifel M
Anticancer Res; 2017 Jun; 37(6):3111-3115. PubMed ID: 28551652
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
[TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
19. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.
Tebbi CK; Mendenhall N; London WB; Williams JL; de Alarcon PA; Chauvenet AR;
Pediatr Blood Cancer; 2006 Feb; 46(2):198-202. PubMed ID: 16136581
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary toxicity due to bleomycin. Report of a case.
Krous HF; Hamlin WB
Arch Pathol; 1973 Jun; 95(6):407-10. PubMed ID: 4121790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
